ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,082, issued on March 11, was assigned to GREEN CROSS Corp. (Yongin, South Korea).

"Highly efficient anti-TFPI antibody composition" was invented by Min Jung Kim (Yongin-si, South Korea), Geun Hye Yeo (Yongin-si, South Korea), Haeng Eun Song (Yongin-si, South Korea), Ji Yoon Park (Yongin-si, South Korea) and Yuna Kim (Yongin-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical highly efficient anti-TFPI antibody composition including an anti-TFPI antibody for treating hemophilia, in which the content of HCP in a drug substance is less than 10.0 ng/mg, and the content of LPA in the drug sub...